Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

INZY Inozyme Pharma Inc

1,355

-0,055 (-3,90%)

Zuletzt aktualisiert: 19:56:32

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Inozyme Pharma (NASDAQ:INZY)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Inozyme Pharma Charts.

Inozyme Pharma (NASDAQ:INZY)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Inozyme Pharma Charts.

News Inozyme Pharma Inc

Form 8-K - Current report
Freitag 10 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Inozyme Pharma Announces Positive Interim Data for INZ-701 in Infants and Young Children with ENPP1 Deficiency and Key Program Updates
Freitag 10 Januar 2025 (2 Wochen vor) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Montag 9 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Inozyme Pharma to Participate in the Piper Sandler 36th Annual Healthcare Conference
Mittwoch 27 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Inozyme Pharma to Present at Upcoming Investor Conferences
Montag 11 November 2024 (3 Monate vor) • GlobeNewswire Inc.

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Freitag 8 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 5 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 5 November 2024 (3 Monate vor) • Edgar (US Regulatory)

Inozyme Pharma Reports Third Quarter 2024 Financial Results and Provides Business Highlights
Dienstag 5 November 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Donnerstag 24 Oktober 2024 (3 Monate vor) • Edgar (US Regulatory)

Inozyme Pharma Announces Positive Interim Data from Phase 1 SEAPORT 1 Trial of INZ-701
Donnerstag 24 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Inozyme Pharma Announces Presentation of Interim Data from Phase 1 SEAPORT 1 Trial at the Upcoming American Society of Nephrology (ASN) Kidney Week 2024
Donnerstag 17 Oktober 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Inozyme Pharma Inc News-Artikel

Botswana Diamond

Arrow DWA Tactical Inter...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen